Oncternal Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ONCT for the last quarter is 801.00 k USD, and it's 40.77% higher compared to the previous quarter. The net income of Q2 24 is -8.56 M USD.